Esperion Therapeutics Inc. (ESPR) Statistics & Valuation Metrics - Stocknear

Esperion Therapeutics Inc...

NASDAQ: ESPR · Real-Time Price · USD
2.53
0.10 (4.12%)
At close: Sep 04, 2025, 3:59 PM
2.53
0.00%
Pre-market: Sep 05, 2025, 08:00 AM EDT

Esperion Therapeutics Statistics

Share Statistics

Esperion Therapeutics has 201.55M shares outstanding. The number of shares has increased by 1.01% in one year.

201.55M
1.01%
0.18%
57.76%
196.96M
23,249
0.44%

Short Selling Information

The latest short interest is 22.64M, so 11.23% of the outstanding shares have been sold short.

22.64M
11.23%
11.28%
3.89

Valuation Ratios

The PE ratio is -7.96 and the forward PE ratio is -243. Esperion Therapeutics's PEG ratio is 0.09.

-7.96
-243
1.24
1.5
-1.06
-17.18
0.09
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Esperion Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of -1.52.

1.37
0.99
-1.52
78.11
-24.66
0.92

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$1.09M
$-170.21K
304
0.97
0.73

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 47.09% in the last 52 weeks. The beta is 0.82, so Esperion Therapeutics's price volatility has been higher than the market average.

0.82
47.09%
1.6
1.66
82.06
5,276,382

Income Statement

In the last 12 months, Esperion Therapeutics had revenue of 332.31M and earned -51.74M in profits. Earnings per share was -0.28.

332.31M
263.71M
54.4M
-51.74M
7.57M
7.51M
-0.28
Full Income Statement

Balance Sheet

The company has 144.76M in cash and 591.21M in debt, giving a net cash position of -446.45M.

144.76M
591.21M
-446.45M
-1.6B
324.03M
47.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.65M and capital expenditures -317K, giving a free cash flow of -23.97M.

-23.65M
-317K
-23.97M
-0.13
Full Cash Flow Statement

Margins

Gross margin is 79.36%, with operating and profit margins of 16.37% and -15.57%.

79.36%
16.37%
-15.57%
-15.57%
2.28%
16.37%
-7.21%

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ESPR is $4, which is 58.1% higher than the current price. The consensus rating is "Buy".

$4
58.1%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-6.88
2